"sbir phase i - fiss-CSC: a fiber-inspired smart scaffold platform for expanding cancer stem cells"
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201500065C
- Awardee
-
Transgenex Nanobiotech Inc. UEI CNWNKZL5QXM1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Opportunity
-
- PHS20151 Solicitation number
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Award Notice · Posted Jul 31, 2014
- Contract value 100% obligated
- $225,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 13 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Tampa, FL 33613, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $225,000 |
About this award
This is a $225,000.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Transgenex Nanobiotech Inc., a Minority Owned, For Profit, Subcontinent Asian (Asian-Indian) American Owned business. The contract is for "SBIR PHASE I - FISS-CSC: A FIBER-INSPIRED SMART SCAFFOLD PLATFORM FOR EXPANDING CANCER STEM CELLS" and was awarded on September 22, 2015 with a completion date of August 21, 2016. This appears to be a Small Business Innovation Research (SBIR) Phase I contract focused on developing a fiber-inspired scaffold platform for expanding cancer stem cells. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN261201500065C?
HHSN261201500065C was awarded to Transgenex Nanobiotech Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500065C worth?
The government has obligated $225,000 on HHSN261201500065C.
Was contract HHSN261201500065C competed?
The extent of competition for HHSN261201500065C was full and open competition. The government received 13 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award